Product image of Blincyto (Blinatumomab) supplied by GNH India

Blincyto

Active Ingredient:
Blinatumomab
Origin:
EU

Blincyto (Blinatumomab)

Blincyto (Blinatumomab) is a targeted therapy used in the treatment of certain types of cancer. This intravenous medication is designed to help the immune system recognize and attack cancer cells.

Manufacturer / TM Owner

Amgen Europe B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Blincyto is primarily used for the treatment of acute lymphoblastic leukemia (ALL) in specific patient populations. It works by binding to CD19-positive cells, which are commonly found on the surface of certain cancer cells. This process helps the body's immune system to identify and destroy these cells. Blincyto is often considered when other treatments have not been effective or are no longer suitable.

Side Effects

  • Common effects of Blincyto may include fever, fatigue, and infusion-related reactions such as chills or nausea. Some patients may experience neurological side effects like confusion or tremors. It is important to monitor for any unusual symptoms and report them to a healthcare provider.

Precautions & Warnings

  • Blincyto should be administered under the supervision of a healthcare professional experienced in the use of this type of therapy. Regular monitoring is essential to manage potential side effects. Patients should be aware of the signs of infection or neurological changes and seek immediate medical attention if these occur.

Avoid Interactions

  • Blincyto may interact with other medications, particularly those that affect the immune system or blood cells. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also affect how Blincyto works, so it is advisable to discuss dietary and lifestyle factors with your healthcare provider.

Frequently Asked Questions

Blincyto is used to treat certain types of acute lymphoblastic leukemia (ALL) by helping the immune system target and destroy cancer cells.

Blincyto is administered intravenously, typically in a clinical setting under the supervision of a healthcare professional.

Common side effects may include fever, fatigue, infusion-related reactions, and neurological symptoms like confusion or tremors.

Blincyto may not be suitable for everyone, particularly those with certain neurological conditions or severe infections. Always consult a healthcare provider.

Blincyto may interact with other medications, so it is important to discuss all current treatments with your healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Blinatumomab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT